Table 1.
Primer sequences used for the detection of intracellular enterovirus E RNA
| Primer | Primer sequence (5′–3′) | Amplicon size | GenBank accession No. |
|---|---|---|---|
| EV-E802 forward | AAAGGGGGCTGTCGAAACCA | 802 | DQ092769.1 |
| EV-E 802 reverse | GCTAGTGGGCTCAGACTCCG | ||
| EV-E 183 forward | TACGCCTTTCGTGGCTTGGA | 183 | |
| EV-E 183 reverse | TTGCTTTTCCTGGCTTGCCG |
Table 2.
Monoclonal antibodies used in the study
| Marker | Expressed by | Fluorochrome | Clone | Isotype |
|---|---|---|---|---|
| CD4 | subset of T cells | FITC | CC8 | IgG2a |
| CD8 | subset of T cells | Alexa Fluor 647 | CC63 | IgG2a |
| WC1 | gamma/delta (γδ) T cells | FITC | CC15 | IgG2a |
| CD21 | B cells | RPE | CC51 | IgG2b |
Table 3.
Serum anti-EV-E antibody titres, intracellular viral RNA levels and extracellular virus titres from bovine PBMCs
| Parameter | Individual | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
| anti-EV-E antibody titer in serum | ND | 1:40 | 1:20 | 1:80 | 1:20 | 1:40 | 1:80 | 1:40 | 1:20 | 1:160 |
| extracellular virus titer (log CCID50/1 mL) | 3.625 | 1.75 | 3.25 | 3.125 | 3.875 | 3.125 | 2.125 | 3.625 | 2.75 | 3.125 |
| intracellular viral RNA (copy number/μL of RNA) | 13.39 | 37.48 | 1.866 | 4913 | 7.133 | 14.82 | 3.852 | 54740 | 20.1 | 9.610 |
Table 4.
Enterovirus E effect on the viability and blastogenic response of bovine peripheral blood mononuclear cells to mitogens shown by the MTT reduction assay, n=10
| Parameter | C | EV-E (MOI) | ||
|---|---|---|---|---|
| 10 | 1 | 0.1 | ||
| viability (%) | 100 ±0 | 58.928** ±19.969 | 80.927 ±20.681 | 104.685 ±31.217 |
| proliferation ConA (SI) | 4.332 ±0.957 | 2.198*** ±0.731 | 4.712 ±1.274 | 3.960 ±0.779 |
| proliferation LPS (SI) high responders | 2.085 ±0.46 | 1.479*** ±0.152 | 1.212*** ±0.298 | 1.095*** ±0.255 |
| proliferation LPS (SI) low responders | 0.924 ±0.112 | 1.084 ±0.120 | 0.925 ±0.160 | 0.880 ±0.140 |

Fig. 1.
Representative dot plot cytograms showing distribution of the main lymphocyte subsets of bovine peripheral blood mononuclear cells after 72 h incubation with a high infectious dose of enterovirus E (EV-E): panel (A) unstimulated cells; (B) concanavalin A-stimulated cells; (C) lipopolysaccharide-stimulated cells. In each panel: upper row – control (uninfected) cells, bottom row – EV-E-infected cells; columns from left to right: lymphocyte gating based on their forward and side scatter (FSC/SSC) properties, T-cell gating according to the expression of CD4 and CD8 markers, B-cell gating according to the expression of CD21 marker and gamma-delta-cell gating according to the expression of WC1 marker
Table 5.
Immunophenotyping of bovine peripheral blood lymphocytes cultured for 72 h in the presence of enterovirus E, n = 5
| Population | Unstimulated | LPS-stimulated | ConA-stimulated | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | EV-E (MOI) | C | EV-E (MOI) | C | EV-E (MOI) | |||||||
| 10 | 1 | 0.1 | 10 | 1 | 0.1 | 10 | 1 | 0.1 | ||||
| CD4+CD8− | 44.80 ±8.73 | 44.86 ±6.30 | 42.98 ±6.93 | 42.46 ±7.24 | 19.38 ±3.15 | 34.55** ±6.53 | 31.02* ±5.99 | 38.30*** ±5.05 | 45.98 ±10.56 | 47.48 ±9.67 | 45.30 ±7.44 | 42.24 ±7.33 |
| CD4-CD8+ | 22.20 ±0.92 | 20.28 ±1.53 | 21.58 ±2.53 | 22.10 ±1.92 | 12.72 ±4.66 | 23.30* ±5.86 | 22.22* ±6.17 | 24.05* ±5.80 | 13.36 ±4.18 | 19.54 ±9.54 | 13.21 ±5.96 | 14.45 ±5.74 |
| CD4+CD8+ | 0.97 ±0.38 | 1.92 ±0.88 | 1.17 ±0.40 | 1.04 ±0.18 | 2.89 ±0.61 | 6.09 ±2.16 | 5.83 ±2.61 | 6.90 ±3.27 | 2.39 ±0.68 | 7.34** ±4.05 | 2.93 ±0.82 | 2.31 ±0.50 |
| CD21+ | 15.38 ±8.23 | 21.96 ±6.49 | 20.30 ±8.61 | 19.59 ±8.30 | 47.86 ±9.94 | 16.39*** ±8.63 | 19.71*** ±9.12 | 11.53*** ±5.86 | 18.55 ±6.67 | 9.49 ±4.88 | 18.46 ±5.31 | 17.66 ±9.02 |
| WC1+ | 4.31 ±3.01 | 1.80 ±1.40 | 5.29 ±3.66 | 5.81 ±4.57 | 4.28 ±1.94 | 2.28 ±1.48 | 3.45 ±1.78 | 3.32 ±0.99 | 16.98 ±10.99 | 18.86 ±12.10 | 14.53 ±9.16 | 13.55 ±9.18 |
Table 6.
Cytokine levels in supernatants from bovine peripheral blood mononuclear cells cultured for 72 h in the presence of enterovirus E, n = 5
| Cytokine (pg/mL) | Unstimulated | LPS-stimulated | ||||||
|---|---|---|---|---|---|---|---|---|
| C | EV-E (MOI) | C | EV-E (MOI) | |||||
| 10 | 1 | 0.1 | 10 | 1 | 0.1 | |||
| IL-1β | 3.56 ±2.38 | 62.09*** ±13.39 | 96.55*** ±17.96 | 24.67* ±5.97 | 21.81 ±6.46 | 5.35** ±3.81 | 24.36 ±4.95 | 17.53 ±7.21 |
| IL-6 | 89.32 ±53.37 | 141.89 ±84.48 | 784.94*** ±284.26 | 864.22*** ±82.46 | 1292.09 ±279.69 | 1209.51 ±179.79 | 1151.45 ±167.52 | 1152.22 ±197.26 |
| TNF-α | 129.09 ±84.32 | 207.14 ±90.41 | 1057.82*** ±441.88 | 1236.32*** ±96.40 | 1780.26 ±456.88 | 2037.78 ±550.99 | 1684.56 ±363.51 | 1682.79 ±356.02 |
Table 7.
Oxidative burst activity of bovine peripheral blood phagocytes after 3 h incubation with enterovirus E, n = 5
| Cell type | Parameter | C | EV-E (MOI) | ||
|---|---|---|---|---|---|
| 10 | 1 | 0.1 | |||
| granulocytes | % | 91.62 ± 4.3 | 92.18 ± 3.98 | 92.94 ± 3.86 | 92.76 ± 4.23 |
| MFI | 1797.6 ± 269.67 | 1774.6 ± 291.22 | 1831.4 ± 280.50 | 1793.8 ± 286.99 | |
| monocytes | % | 43.32 ± 7.70 | 32.62 ± 3.74 | 35.90 ± 6.94 | 37.46 ± 6.65 |
| MFI | 299.2 ± 87.04 | 208.4 ± 71.53 | 240.2 ± 74.89 | 247.2 ± 93.38 | |